Literature DB >> 25004323

A child with severe hearing loss associated with maternal cisplatin treatment during pregnancy.

Eric C T Geijteman1, Celesta W M Wensveen, Johannes J Duvekot, Lia van Zuylen.   

Abstract

BACKGROUND: Cisplatin is considered safe to use during the second and third trimesters of pregnancy in patients with cancer. CASE: A 34-year-old pregnant woman was diagnosed with cervical cancer. She received five weekly dosages of cisplatin and paclitaxel, starting at 26 5/7 weeks of gestation. An elective cesarean delivery was performed at 34 4/7 weeks of gestation. After birth, the neonate was diagnosed with severe bilateral perceptive hearing loss.
CONCLUSION: Cisplatin during the second and third trimesters of pregnancy may lead to fetal ototoxicity.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25004323     DOI： 10.1097/AOG.0000000000000389

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


  12 in total

Review 1.  Transplacental Passage and Fetal Effects of Antineoplastic Treatment during Pregnancy.

Authors:  Silvia Triarico; Serena Rivetti; Michele Antonio Capozza; Alberto Romano; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà; Antonio Ruggiero
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

2.  The impact of cancer and chemotherapy during pregnancy on child neurodevelopment: A multimodal neuroimaging analysis.

Authors:  J Blommaert; A Radwan; C Sleurs; C Maggen; M van Gerwen; V Wolters; D Christiaens; R Peeters; P Dupont; S Sunaert; K Van Calsteren; S Deprez; F Amant
Journal:  EClinicalMedicine       Date:  2020-10-21

Review 3.  Individual management of cervical cancer in pregnancy.

Authors:  Thomas Hecking; Alina Abramian; Christian Domröse; Tabea Engeln; Thore Thiesler; Claudia Leutner; Ulrich Gembruch; Mignon-Denise Keyver-Paik; Walther Kuhn; Kirsten Kübler
Journal:  Arch Gynecol Obstet       Date:  2016-01-04       Impact factor: 2.344

4.  Associations Between TGFA/TGFB3/MSX1 Gene Polymorphisms and Congenital Non-Syndromic Hearing Impairment in a Chinese Population.

Authors:  Jihong Du; Jianhua Deng
Journal:  Med Sci Monit       Date:  2016-06-29

5.  Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis.

Authors:  Yizuo Song; Yi Liu; Min Lin; Bo Sheng; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2018-12-19       Impact factor: 4.162

Review 6.  Pregnancy and Cancer: the INCIP Project.

Authors:  Charlotte Maggen; Vera E R A Wolters; Elyce Cardonick; Monica Fumagalli; Michael J Halaska; Christianne A R Lok; Jorine de Haan; Katrien Van Tornout; Kristel Van Calsteren; Frédéric Amant
Journal:  Curr Oncol Rep       Date:  2020-02-05       Impact factor: 5.075

Review 7.  Management of pregnancy in women with cancer.

Authors:  Vera Wolters; Joosje Heimovaara; Charlotte Maggen; Elyce Cardonick; Ingrid Boere; Liesbeth Lenaerts; Frédéric Amant
Journal:  Int J Gynecol Cancer       Date:  2021-03       Impact factor: 3.437

8.  Congenital bilateral cryptorchidism in an infant conceived after maternal breast cancer treatment: A case report.

Authors:  Wei-Kai Hu; Jing Liu; Rui-Xia Liu; Xiao-Wei Liu; Cheng-Hong Yin
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

9.  A case of successful maintained pregnancy after neoadjuvant chemotherapy plus radical surgery for stage IB3 cervical cancer diagnosed at 13 weeks.

Authors:  Ying Guo; Dandan Zhang; Yuhong Li; Yudong Wang
Journal:  BMC Pregnancy Childbirth       Date:  2020-04-07       Impact factor: 3.007

10.  Clinicopathological Characteristics and Treatment Outcomes of Pregnancy Complicated by Malignant Ovarian Germ Cell Tumors.

Authors:  Xuan Zong; Jia-Xin Yang; Ying Zhang; Dong-Yan Cao; Keng Shen
Journal:  Cancer Manag Res       Date:  2020-02-24       Impact factor: 3.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.